Andorra vs Republic of Moldova: Deaths from Parkinson's disease
Andorra
5.15 deaths
in 2021
Republic of Moldova
9.6 deaths
in 2021
Andorra rank
175th
Republic of Moldova rank
172nd
Deaths from Parkinson's disease over time
- Andorra
- Republic of Moldova
How they compare
Republic of Moldova currently reports 9.6 deaths against 5.15 deaths in Andorra, a difference of 4.45 deaths.
That makes Republic of Moldova's figure about 1.9 times Andorra's.
The two have swapped places 7 times across 22 shared years of data; in 2000 it was Andorra ahead.
Andorra ranks 175th and Republic of Moldova ranks 172nd of 194 countries.
Republic of Moldova has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.07 deaths | 6.95 deaths | 1.88 deaths | Republic of Moldova |
| 2010s | 5.06 deaths | 6.89 deaths | 1.84 deaths | Republic of Moldova |
| 2020s | 4.7 deaths | 8.25 deaths | 3.55 deaths | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from parkinson's disease, Andorra or Republic of Moldova?
- Republic of Moldova, at 9.6 deaths against 5.15 deaths in Andorra as of 2021.
- What is the difference in deaths from parkinson's disease between Andorra and Republic of Moldova?
- 4.45 deaths, with Republic of Moldova ahead.
- How many years of comparable data are there for Andorra and Republic of Moldova?
- 22 years are reported by both, from 2000 to 2021.
- How do Andorra and Republic of Moldova rank globally for deaths from parkinson's disease?
- Andorra ranks 175th and Republic of Moldova ranks 172nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes.